Loading stock data…
China SXT Pharmaceuticals (SXTC)
$2.03-0.39 (-16.12%)
After Hours$2.17+0.14 (+6.90%)· Last close Jun 29
China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
China SXT Pharmaceuticals, Inc. in the Healthcare sector is trading at $2.02 with a market capitalization of $11M. The stock is currently near its 52-week low of $1.25, remaining 97.9% below its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality, Altman Z in the distress zone. The Whystock Score of 50/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Long-term trend bearish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q3 2025 | Q1 2025 | Q3 2024 | Q1 2024 | Q3 2023 |
|---|---|---|---|---|---|
| Total Revenue | — | — | — | — | — |
| Gross Profit | — | — | — | — | — |
| Operating Income | — | — | — | — | — |
| Net Income | — | — | — | — | — |
Peer Comparison
JNJUNHPFE
Fundamentals
China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, an...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$10.75M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-
Volume
Today's trading volume
260,386
Recent News
BC-Most Active Stocks
Elong Power Holding Ltd. 31,796,929 2.31
China SXT Pharmaceuticals Full Year 2025 Earnings: US$2.32 loss per share (vs US$28.58 loss in FY 2024)
China SXT Pharmaceuticals ( NASDAQ:SXTC ) Full Year 2025 Results Key Financial Results Revenue: US$1.74m (down 9.7...
US Market's Undiscovered Gems Featuring 3 Promising Stocks
As the United States market continues to experience robust economic growth and strong corporate earnings, major indices like the S&P 500 and Nasdaq Composite are reaching new heights, driven by optimism despite lingering tariff concerns. In this dynamic environment, identifying promising stocks requires a keen eye for companies that demonstrate resilience and potential for growth amid broader market trends.
Undiscovered Gems in the US Market for July 2025
Over the last seven days, the United States market has remained flat, yet it has seen a significant 16% increase over the past year with expectations of earnings growing by 15% annually in the coming years. In this dynamic environment, identifying stocks that are not only resilient but also poised to capitalize on growth opportunities can be key to uncovering potential undiscovered gems.
US Undiscovered Gems with Strong Potential July 2025
As the S&P 500 and Nasdaq Composite continue to reach new highs, fueled by strong corporate earnings and easing tariff concerns, investors are closely watching the Federal Reserve's upcoming meeting on interest rates. This environment of optimism and economic resilience presents a fertile ground for identifying promising opportunities among small-cap stocks. In this context, discovering stocks with solid fundamentals and growth potential can be particularly rewarding, as they may offer unique...